Ads
related to: narcolepsy treatment- Living With Narcolepsy
Learn How to Manage Living With
Your EDS and/or Cataplexy Today.
- Potential Health Risks
Learn About the Potential Risks
of EDS and/or Cataplexy Treatment.
- Patient Brochure
Learn Important Information
About the Treatment.
- Discover Patient Stories
Learn More About The Daily Life of
Patients Living With Narcolepsy.
- Narcolepsy Health
Learn How to Treat Cataplexy
& or EDS in Narcolepsy.
- Doctor Discussion Guide
Talk to Your Doctor Today to
See if Treatment May Be an Option.
- Living With Narcolepsy
Search results
NLS reports narcolepsy treatment progress at ASCP By Investing.com
Investing.com· 2 days agoZÜRICH - NLS Pharmaceutics Ltd. (NASDAQ:NLSP), a Swiss biopharmaceutical company, has announced...
NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects...
Digital Journal· 2 days ago"These data underscore our continued commitment to advancing our pipeline which has the potential to change the treatment paradigm for patients impacted by sleep and wakefulness ...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 22 hours agoJ&J is studying the drug, called seltorexant, as an “adjunctive” therapy to background treatment...
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
InvestorPlace· 5 days agoAs we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused...
7 Blue-Chip Stocks to Buy Now: May 2024
InvestorPlace via Yahoo Finance· 7 days agoIf the market’s dramatic shifts this year have left you feeling unsettled, you’re not alone. Despite widespread overvaluation in many tech stocks, plenty...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoHAMILTON, BERMUDA / May 28, 2024 / Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets ...
Victory Capital Management Inc. Has $415,000 Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
ETF DAILY NEWS· 5 days agoVictory Capital Management Inc. trimmed its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 72.5% during the fourth quarter, HoldingsChannel reports. The fund ...
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Victory Capital Management Inc.
ETF DAILY NEWS· 6 days agoVictory Capital Management Inc. reduced its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 45.4% in the 4th quarter, according to its most recent disclosure ...
Ads
related to: narcolepsy treatment